A Post Market Prospective Study of FORTIVA® 1mm Porcine Dermis — APPeaR

Mammoplasty Clinical Trial

Official title:
A Post Market Prospective Study of FORTIVA® 1mm Porcine Dermis in Breast Reconstruction

Status Completed

Clinical Trial Summary

This is a post market prospective, multi-center study of up to 100 subjects undergoing post-mastectomy breast reconstruction (50 Fortiva® 1mm perforated and 50 Fortiva® 1mm non-perforated) at up to 10 clinical study sites in Europe.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Mammoplasty

Clinical Trial Details

NCT number	NCT03744013
Study type	Interventional
Source	RTI Surgical
Contact
Status	Completed
Phase	N/A
Start date	May 7, 2019
Completion date	January 9, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00505557` - Dual-Plane Breast Augmentation: Axillary Approach With Assistant of Endoscope	Phase 1
Active, not recruiting	`NCT06079086` - Evaluation of the Clinical Evolution of Breast Increase Using Prostheses	N/A
Recruiting	`NCT04307355` - Continuous Diffusion of Oxygen Treatment for Incision Wounds	Phase 1/Phase 2
Completed	`NCT03213249` - Bacterial Biofilms in Reconstructive Breast Prostheses Following Mastectomy	Phase 1
Completed	`NCT04331080` - A Study of Granexin® Gel for the Reduction of Scar Formation in Surgical Wounds Following Bilateral Anchor Incision Breast Surgery	Phase 2/Phase 3
Completed	`NCT01582490` - Study of EXPAREL in Patients Undergoing Breast Augmentation	Phase 4